SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 51.06 |
Enterprise Value ($M) | 53.89 |
Book Value ($M) | 13.46 |
Book Value / Share | 0.36 |
Price / Book | 3.79 |
NCAV ($M) | -8.65 |
NCAV / Share | -0.23 |
Price / NCAV | -5.90 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.26 |
Return on Assets (ROA) | -0.57 |
Return on Equity (ROE) | -0.77 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.73 |
Current Ratio | 0.73 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 6.40 |
Assets | 28.51 |
Liabilities | 15.05 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 2.84 |
Operating Income | -25.72 |
Net Income | -24.99 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -22.51 |
Cash from Investing | 3.80 |
Cash from Financing | -0.01 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 1) | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
145 | 5,199 | 2.79 | |
2,225 | 226 | 984.51 | |
763 | 30 | 2,543.33 | |
2,530 | 1,808 | 139.93 | |
404 | 205 | 197.07 | |
(click for more detail) |
Similar Companies | |
---|---|
GHRS – GH Research PLC | GLYC – GlycoMimetics, Inc. |
GRTX – Galera Therapeutics, Inc. | HRMY – Harmony Biosciences Holdings, Inc. |
HROW – Harrow, Inc. |
Financial data and stock pages provided by
Fintel.io